Do analysts rate SCPA or IOF?

Iofina has a consensus price target of GBX 65, indicating a potential upside of 16.70%. Given Iofina's stronger consensus rating and higher probable upside, analysts clearly believe Iofina is more favorable than Scapa Group. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Scapa Group 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00 Iofina 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00

Which has better valuation and earnings, SCPA or IOF?

Iofina has lower revenue, but higher earnings than Scapa Group. Scapa Group is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Scapa Group £281.80M 0.00 N/A -£29.30 N/A Iofina £66.52M 1.61 £4.28M £4.00 13.93

Is SCPA or IOF more profitable?

Iofina has a net margin of 11.84% compared to Scapa Group's net margin of 0.00%. Iofina's return on equity of 14.89% beat Scapa Group's return on equity. Company Net Margins Return on Equity Return on Assets Scapa Group N/A N/A N/A Iofina 11.84% 14.89% 5.18%

Which has better valuation & earnings, IOF or ESNT?

Iofina has higher earnings, but lower revenue than Essentra. Iofina is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Iofina £66.52M 1.61 £4.28M £4.00 13.93 Essentra £315.70M 0.97 £3.50M £0.70 154.29

Is IOF or ESNT more profitable?

Iofina has a net margin of 11.84% compared to Essentra's net margin of 1.71%. Iofina's return on equity of 14.89% beat Essentra's return on equity. Company Net Margins Return on Equity Return on Assets Iofina 11.84% 14.89% 5.18% Essentra 1.71% 2.02% 1.74%

Does the media refer more to IOF or ESNT?

In the previous week, Essentra had 5 more articles in the media than Iofina. MarketBeat recorded 6 mentions for Essentra and 1 mentions for Iofina. Essentra's average media sentiment score of 0.67 beat Iofina's score of 0.67 indicating that Essentra is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Iofina 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Essentra 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better earnings & valuation, ZTF or IOF?

Zotefoams has higher revenue and earnings than Iofina. Zotefoams is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Zotefoams £158.49M 1.43 £9.80M £44.87 10.27 Iofina £66.52M 1.61 £4.28M £4.00 13.93

Is ZTF or IOF more profitable?

Zotefoams has a net margin of 14.28% compared to Iofina's net margin of 11.84%. Zotefoams' return on equity of 18.25% beat Iofina's return on equity. Company Net Margins Return on Equity Return on Assets Zotefoams 14.28% 18.25% 5.48% Iofina 11.84% 14.89% 5.18%

Which has preferable valuation & earnings, TET or IOF?

Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Treatt £128.29M 1.40 £11.22M £7.22 42.24 Iofina £66.52M 1.61 £4.28M £4.00 13.93

Is TET or IOF more profitable?

Iofina has a net margin of 11.84% compared to Treatt's net margin of 3.40%. Iofina's return on equity of 14.89% beat Treatt's return on equity. Company Net Margins Return on Equity Return on Assets Treatt 3.40% 3.22% 6.72% Iofina 11.84% 14.89% 5.18%

Which has higher earnings & valuation, IOF or SYNT?

Iofina has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Iofina £66.52M 1.61 £4.28M £4.00 13.93 Synthomer £1.74B 0.09 -£82.04M -£96.00 N/A

Is IOF or SYNT more profitable?

Iofina has a net margin of 11.84% compared to Synthomer's net margin of -9.03%. Iofina's return on equity of 14.89% beat Synthomer's return on equity. Company Net Margins Return on Equity Return on Assets Iofina 11.84% 14.89% 5.18% Synthomer -9.03% -16.66% -0.28%

Does the media favor IOF or SYNT?

In the previous week, Synthomer had 6 more articles in the media than Iofina. MarketBeat recorded 7 mentions for Synthomer and 1 mentions for Iofina. Iofina's average media sentiment score of 0.67 beat Synthomer's score of 0.00 indicating that Iofina is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Iofina 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Synthomer 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Iofina (IOF) Competitors

GBX 55.70 -0.30 (-0.54%)

As of 10:20 AM Eastern

Compare

IOF vs. SCPA, ESNT, ZTF, TET, and SYNT

Should you buy Iofina stock or one of its competitors? MarketBeat compares Iofina with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Iofina include Scapa Group (SCPA), Essentra (ESNT), Zotefoams (ZTF), Treatt (TET), and Synthomer (SYNT).

How does Iofina compare to Scapa Group?

Scapa Group (LON:SCPA) and Iofina (LON:IOF) are both small-cap materials companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, dividends, profitability, media sentiment, risk, earnings and valuation.

Iofina has lower revenue, but higher earnings than Scapa Group. Scapa Group is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Scapa Group	£281.80M	0.00	N/A	-£29.30	N/A
Iofina	£66.52M	1.61	£4.28M	£4.00	13.93

1.5% of Iofina shares are held by institutional investors. 13.4% of Iofina shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Iofina has a consensus price target of GBX 65, indicating a potential upside of 16.70%. Given Iofina's stronger consensus rating and higher probable upside, analysts clearly believe Iofina is more favorable than Scapa Group.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Scapa Group	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	0.00
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

In the previous week, Iofina had 1 more articles in the media than Scapa Group. MarketBeat recorded 1 mentions for Iofina and 0 mentions for Scapa Group. Iofina's average media sentiment score of 0.67 beat Scapa Group's score of 0.00 indicating that Iofina is being referred to more favorably in the news media.

Company	Overall Sentiment
Scapa Group	Neutral
Iofina	Positive

Iofina has a net margin of 11.84% compared to Scapa Group's net margin of 0.00%. Iofina's return on equity of 14.89% beat Scapa Group's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Scapa Group	N/A	N/A	N/A
Iofina	11.84%	14.89%	5.18%

Summary

Iofina beats Scapa Group on 12 of the 13 factors compared between the two stocks.

How does Iofina compare to Essentra?

Iofina (LON:IOF) and Essentra (LON:ESNT) are related small-cap companies, but which is the better business? We will compare the two companies based on the strength of their valuation, media sentiment, risk, analyst recommendations, profitability, institutional ownership, dividends and earnings.

1.5% of Iofina shares are owned by institutional investors. Comparatively, 69.5% of Essentra shares are owned by institutional investors. 13.4% of Iofina shares are owned by insiders. Comparatively, 0.5% of Essentra shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Iofina has a net margin of 11.84% compared to Essentra's net margin of 1.71%. Iofina's return on equity of 14.89% beat Essentra's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Iofina	11.84%	14.89%	5.18%
Essentra	1.71%	2.02%	1.74%

Iofina currently has a consensus target price of GBX 65, suggesting a potential upside of 16.70%. Essentra has a consensus target price of GBX 132.50, suggesting a potential upside of 22.69%. Given Essentra's higher possible upside, analysts plainly believe Essentra is more favorable than Iofina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Essentra	0 Sell rating(s)	1 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.75

Iofina has higher earnings, but lower revenue than Essentra. Iofina is trading at a lower price-to-earnings ratio than Essentra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iofina	£66.52M	1.61	£4.28M	£4.00	13.93
Essentra	£315.70M	0.97	£3.50M	£0.70	154.29

Iofina has a beta of 0.86, suggesting that its share price is 14% less volatile than the broader market. Comparatively, Essentra has a beta of 0.829, suggesting that its share price is 17% less volatile than the broader market.

In the previous week, Essentra had 5 more articles in the media than Iofina. MarketBeat recorded 6 mentions for Essentra and 1 mentions for Iofina. Essentra's average media sentiment score of 0.67 beat Iofina's score of 0.67 indicating that Essentra is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Iofina	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Essentra	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

Iofina beats Essentra on 9 of the 16 factors compared between the two stocks.

How does Iofina compare to Zotefoams?

Zotefoams (LON:ZTF) and Iofina (LON:IOF) are both small-cap materials companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, profitability, analyst recommendations, dividends, institutional ownership, media sentiment, valuation and risk.

Zotefoams has a net margin of 14.28% compared to Iofina's net margin of 11.84%. Zotefoams' return on equity of 18.25% beat Iofina's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Zotefoams	14.28%	18.25%	5.48%
Iofina	11.84%	14.89%	5.18%

Zotefoams has higher revenue and earnings than Iofina. Zotefoams is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Zotefoams	£158.49M	1.43	£9.80M	£44.87	10.27
Iofina	£66.52M	1.61	£4.28M	£4.00	13.93

In the previous week, Iofina had 1 more articles in the media than Zotefoams. MarketBeat recorded 1 mentions for Iofina and 0 mentions for Zotefoams. Iofina's average media sentiment score of 0.67 beat Zotefoams' score of 0.00 indicating that Iofina is being referred to more favorably in the news media.

Company	Overall Sentiment
Zotefoams	Neutral
Iofina	Positive

Zotefoams has a beta of 1.239, suggesting that its stock price is 24% more volatile than the broader market. Comparatively, Iofina has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

Zotefoams presently has a consensus price target of GBX 605, suggesting a potential upside of 31.24%. Iofina has a consensus price target of GBX 65, suggesting a potential upside of 16.70%. Given Zotefoams' higher possible upside, equities research analysts plainly believe Zotefoams is more favorable than Iofina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Zotefoams	0 Sell rating(s)	0 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	3.00
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

29.4% of Zotefoams shares are owned by institutional investors. Comparatively, 1.5% of Iofina shares are owned by institutional investors. 4.5% of Zotefoams shares are owned by insiders. Comparatively, 13.4% of Iofina shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Zotefoams beats Iofina on 10 of the 15 factors compared between the two stocks.

How does Iofina compare to Treatt?

Treatt (LON:TET) and Iofina (LON:IOF) are both small-cap materials companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Treatt has a beta of 0.907, suggesting that its stock price is 9% less volatile than the broader market. Comparatively, Iofina has a beta of 0.86, suggesting that its stock price is 14% less volatile than the broader market.

In the previous week, Iofina had 1 more articles in the media than Treatt. MarketBeat recorded 1 mentions for Iofina and 0 mentions for Treatt. Iofina's average media sentiment score of 0.67 beat Treatt's score of 0.00 indicating that Iofina is being referred to more favorably in the news media.

Company	Overall Sentiment
Treatt	Neutral
Iofina	Positive

17.5% of Treatt shares are owned by institutional investors. Comparatively, 1.5% of Iofina shares are owned by institutional investors. 4.1% of Treatt shares are owned by company insiders. Comparatively, 13.4% of Iofina shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Treatt has higher revenue and earnings than Iofina. Iofina is trading at a lower price-to-earnings ratio than Treatt, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Treatt	£128.29M	1.40	£11.22M	£7.22	42.24
Iofina	£66.52M	1.61	£4.28M	£4.00	13.93

Iofina has a net margin of 11.84% compared to Treatt's net margin of 3.40%. Iofina's return on equity of 14.89% beat Treatt's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Treatt	3.40%	3.22%	6.72%
Iofina	11.84%	14.89%	5.18%

Treatt presently has a consensus target price of GBX 248.33, indicating a potential downside of 18.58%. Iofina has a consensus target price of GBX 65, indicating a potential upside of 16.70%. Given Iofina's stronger consensus rating and higher possible upside, analysts clearly believe Iofina is more favorable than Treatt.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Treatt	0 Sell rating(s)	2 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.33
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00

Summary

Iofina beats Treatt on 8 of the 15 factors compared between the two stocks.

How does Iofina compare to Synthomer?

Iofina (LON:IOF) and Synthomer (LON:SYNT) are both small-cap materials companies, but which is the superior stock? We will contrast the two businesses based on the strength of their earnings, profitability, media sentiment, analyst recommendations, valuation, dividends, risk and institutional ownership.

Iofina has a beta of 0.86, meaning that its share price is 14% less volatile than the broader market. Comparatively, Synthomer has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market.

Iofina has a net margin of 11.84% compared to Synthomer's net margin of -9.03%. Iofina's return on equity of 14.89% beat Synthomer's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Iofina	11.84%	14.89%	5.18%
Synthomer	-9.03%	-16.66%	-0.28%

Iofina presently has a consensus target price of GBX 65, suggesting a potential upside of 16.70%. Synthomer has a consensus target price of GBX 109.40, suggesting a potential upside of 17.63%. Given Synthomer's higher possible upside, analysts plainly believe Synthomer is more favorable than Iofina.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Iofina	0 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	3.00
Synthomer	0 Sell rating(s)	4 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, Synthomer had 6 more articles in the media than Iofina. MarketBeat recorded 7 mentions for Synthomer and 1 mentions for Iofina. Iofina's average media sentiment score of 0.67 beat Synthomer's score of 0.00 indicating that Iofina is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Iofina	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Synthomer	2 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Iofina has higher earnings, but lower revenue than Synthomer. Synthomer is trading at a lower price-to-earnings ratio than Iofina, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Iofina	£66.52M	1.61	£4.28M	£4.00	13.93
Synthomer	£1.74B	0.09	-£82.04M	-£96.00	N/A

1.5% of Iofina shares are owned by institutional investors. Comparatively, 15.3% of Synthomer shares are owned by institutional investors. 13.4% of Iofina shares are owned by insiders. Comparatively, 5.0% of Synthomer shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Iofina beats Synthomer on 10 of the 15 factors compared between the two stocks.

Get Iofina News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IOF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IOF vs. The Competition

Export

Metric	Iofina	Chemicals Industry	Materials Sector	LON Exchange
Market Cap	£106.87M	£11.12B	£4.66B	£2.85B
Dividend Yield	2.88%	2.85%	4.76%	6.16%
P/E Ratio	13.93	20.94	20.35	368.08
Price / Sales	1.61	52.78	5,007.12	83,644.50
Price / Cash	7.96	14.97	24.35	27.89
Price / Book	2.48	3.63	8.29	7.04
Net Income	£4.28M	£223.51M	£155.10M	£5.89B
7 Day Performance	-6.32%	0.93%	1.12%	0.55%
1 Month Performance	7.12%	0.34%	-2.52%	0.25%
1 Year Performance	127.35%	21.06%	38.91%	64.61%

Iofina Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IOF Iofina	3.2171 of 5 stars	GBX 55.70 -0.5%	GBX 65 +16.7%	+133.3%	£106.87M	£66.52M	13.93	95
SCPA Scapa Group	N/A	N/A	N/A	N/A	£402.98M	£281.80M	N/A	1,461
ESNT Essentra	2.5 of 5 stars	GBX 95.70 +4.8%	GBX 150 +56.7%	+3.7%	£271.27M	£302M	136.71	350	Earnings Report Gap Down
ZTF Zotefoams	N/A	GBX 450 -1.6%	GBX 605 +34.4%	+65.7%	£230.91M	£158.49M	10.03	549	Gap Up
TET Treatt	N/A	GBX 305 flat	GBX 248.33 -18.6%	N/A	£180.06M	£128.29M	42.24	350

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (LON:IOF) was last updated on 8/4/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Iofina (IOF) Competitors